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A PROTEOME ANALYSIS
R. Faissnera, A. Funka, S. Wandschneiderb, M. Schno¨lzerb,
J.-M. Lo¨hra. aDepartment of Medicine II, Mannheim Medical Faculty,
University of Heidelberg, Germany; bCentral Protein Analysis, DKFZ,
Heidelberg, Germany.
Background: Tumors of the pancreas are characterized by a high
potency to develop chemoresistance towards cytostatic drugs,
which is the main cause of ineffective treatment. The biological
mechanisms of this resistance are still unknown. We used a pro-
teomic approach to analyse protein regulation of pancreatic cell
lines treated with cytostatic drugs.
Methods: Three human pancreatic cancer cell lines (PANC-1,
Paca44, CAPAN-1) were treated with 5-FU, Gemcitabine and
Mafosfamide for 24 h. A 5-FU resistant CAPAN-1 cell line was
developed through exposure to increasing concentrations of 5-
FU. High-resolution 2D-gels were produced (IEF, SDS–PAGE) and
the resulting gels were stained and digitalized. Image analysis
was performed (PDQuest) and differentially regulated proteins
were excised from the gel, digested, and submitted to mass spec-
trometry (MALDI-TOF-MS). Proteins were identified by Peptide
Mass Fingerprint (PMF).
Results: We identified more than 80 cell line protein spots to date.
Image analysis showed that more than 10 protein spots are differ-
entially regulated – one of them identified as annexin IV. Work is
ongoing to identify all differentially expressed proteins.
Conclusions: The proteomic approach is a solid and reproducible
method for identifying differentially regulated proteins. Identifi-
cation of chemoresistance-related proteins will further our
understanding of the biological mechanism of chemoresistance
and may lead to novel cyctostatic drugs.
doi:10.1016/j.ejcsup.2006.04.076
P17. EFFECTS OF TUMOR–STROMA INTERACTION ON
GLOBAL GENE EXPRESSION IN BREAST CANCER
Martin Buessa, Dimitry S.A. Nuytenb, Trevor Hastiea, Patrick
O. Browna. aStanford University, Stanford, CA, USA; bNetherlands
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Background: Perturbation in intercellular communication are a
key feature of cancer. However, the systematic effects of cell–cell
interaction on global gene expression in cancer are largely
unexplored.
Methods: We simulated tumor–stroma interaction in vitro by
systematically co-cultivating each of seven different breast can-
cer cell lines with stromal fibroblasts from three different sites,
and determined associated gene expression changes with cDNA
microarrays. A dataset of pretreatment gene expression profiles
from 295 early stage breast cancers (stages 1 and 2) with a follow
up of 12.6 years allowed us to evaluate the prognostic significance
of the gene expression signatures of specific cell–cell interactions
derived from our ex vivo models.
Results: Co-culturing normal human breast epithelial cells and
breast cancer cells with stromal fibroblasts revealed multipleeffects on gene expression. The most prominent was an up-regu-
lation of interferon-response genes (IRG), which was detected in
about half of the breast cancer co-cultures, but not with normal
mammary epithelial cells. In vivo, expression of the IRG was
remarkably coherent, providing a basis for segregation of the
295 early-stage breast cancers into two groups. Tumors with high
expression levels (n = 161) of IRG were associated with signifi-
cantly shorter overall survival; 59% at 10 years versus 80% at 10
years for tumors with low expression levels (n = 134) (log-rank
p = 0.001).
Conclusion: This suggests that an interaction between some
breast cancer cells and stromal fibroblasts can induce an inter-
feron response, and that this response may be associated with a
greater propensity for tumor progression.
doi:10.1016/j.ejcsup.2006.04.077
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OF PRIMARY PROSTATE CANCER
U. Schmidta, S. Fuessela, R. Kochb, G.B. Barettonc, M. Froehnera,
M.P. Wirtha, A. Meyea. aDepartment of Urology, Technical University
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Background: This study describes the evaluation of the expres-
sion pattern of prostate-specific transcripts in 106 matched pros-
tate tissues as predictors for prostate cancer (PCa). RNA was
prepared from cryo-preserved paired malignant and non-malig-
nant prostate specimens, which had been removed during radical
prostatectomy and examined by a trained pathologist.
Methods: Quantitative PCR (QPCR) assays with site-specific
hybridization probes were established for four housekeeping
genes and nine prostate-specific genes (AibZIP, DD3/PCA3, D-
GPCR, EZH2, PDEF, prostein, PSA, PSCA, TRPM8). In the analyzed
patient cohort, statistical differences for the commonly used
housekeeping genes GAPDH (p = 0.038), HPRT (p = 0.036) and PBGD
(p = 0.00003) were observed.
Results: The only housekeeping gene being not differentially
expressed between malignant and non-malignant prostate tis-
sues was TBP (p = 0.531). Therefore, all expression was normal-
ized to TBP. The logarithmized relative mRNA expression of
AibZIP, DD3/PCA3, D-GPCR, EZH2, PDEF (all p < 0.001), prostein
(p = 0.019), PSA (p < 0.001) and TRPM8 (p < 0.001) were significantly
higher in malignant vs. non-malignant prostate tissues. Receiver
operating characteristic (ROC) curves were generated, and their
areas under the curve (AUC) were calculated for all single param-
eters. DD3/PCA3 is the marker with the highest AUC (0.85), i.e. the
best single tumor marker. A logit model was developed which
employs the logarithmized relative expression levels of DD3/
PCA3, EZH2, prostein and TRPM8 and yields an AUC of 0.90.
Conclusion: It can be concluded that DD3/PCA3 is a powerful
predictor of PCa but the addition of EZH2, prostein and TRPM8
adds even more to the predictive power.
doi:10.1016/j.ejcsup.2006.04.078
